Wegovy’s launch in Thailand marks the injectable drug’s first entry into the Southeast Asia market. Wegovy, initially launched in 2021, has played a key role in making Novo Nordisk Europe’s most valuable listed company. Read The Full Blog: https://www.coherentmarketinsights.com/news/novo-nordisk-launches-its-blockbuster-obesity-drug-wegovy-in-thailand-1236 https://www.coherentmarketinsights.com/news/novo-nordisk-launches-its-blockbuster-obesity-drug-wegovy-in-thailand-1236